APO Research
Talk to an analyst

APO RESEARCH · REPORT

Implantable Neurostimulators

An implantable neurostimulator is a surgically placed device about the size of a stopwatch. It delivers mild electrical signals to the epidural space near your spine through one or more thin wires, called leads. A complete implantable neurostimulation system includes several components: Neurostimulator, Leads, Physician’s programmer, Patient’s programmer.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

An implantable neurostimulator is a surgically placed device about the size of a stopwatch. It delivers mild electrical signals to the epidural space near your spine through one or more thin wires, called leads. A complete implantable neurostimulation system includes several components: Neurostimulator, Leads, Physician’s programmer, Patient’s programmer.

Selected research

Market Structure

Global Implantable Neurostimulators Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

1 January 2026190 pages

Choose your research edition.

Industry ResearchImplantable Neurostimulators Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Implantable Neurostimulators Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Implantable Neurostimulators Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Implantable Neurostimulators Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Implantable Neurostimulators Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

An implantable neurostimulator is a surgically placed device about the size of a stopwatch. It delivers mild electrical signals to the epidural space near your spine through one or more thin wires, called leads. A complete implantable neurostimulation system includes several components: Neurostimulator, Leads, Physician’s programmer, Patient’s programmer.

The major players in United States Implantable Neurostimulators market include Medtronic, Boston Scientific, etc. The top 2 players occupy about 60% shares of the whole market. Mid-Atlantic Region and South Atlantic are main markets, they occupy about 40% of the whole market. Spinal Cord Stimulators is the main type, with a share about 55%. Pain is the main application, which holds a share about 55%.

This report provides an overview of the global Implantable Neurostimulators market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Implantable Neurostimulators and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Implantable Neurostimulators sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Implantable Neurostimulators market size, projected growth trends, production technologies, key applications, and end-use industries.

Implantable Neurostimulators Segment by Company

Medtronic

Boston Scientific

St. Jude Medical

Cyberonics

NeuroPace

Synapse Biomedical

NeuroSigma

ReShape Lifesciences

ElectroCore Medical

Inspire Medical

NEUROS

SPR

IMTHERA

NEVRO

Implantable Neurostimulators Segment by Type

Deep Brain Stimulators

Spinal Cord Stimulators

Vagal Nerve Stimulators

Sacral Nerve Stimulators

Gastric Stimulators

Others

Implantable Neurostimulators Segment by Application

Parkinson's Disease

Epilepsy

Pain

Others

Implantable Neurostimulators Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Implantable Neurostimulators market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Implantable Neurostimulators and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Implantable Neurostimulators.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Implantable Neurostimulators market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Implantable Neurostimulators manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Implantable Neurostimulators in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Implantable Neurostimulators in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Implantable Neurostimulators Industry Trends Table 2. Implantable Neurostimulators Industry Drivers Table 3. Implantable Neurostimulators Industry Opportunities and Challenges Table 4. Implantable Neurostimulators Industry Restraints Table 5. Global Implantable Neurostimulators Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Implantable Neurostimulators Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Implantable Neurostimulators Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Implantable Neurostimulators Sales Market Share by Manufacturers Table 9. Global Implantable Neurostimulators Average Sales Price (K US$/Unit) of Manufacturers (2021-2026) Table 10. Global Implantable Neurostimulators Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Implantable Neurostimulators Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Implantable Neurostimulators Manufacturers, Product Type & Application Table 13. Global Implantable Neurostimulators Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Implantable Neurostimulators by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Deep Brain Stimulators Table 17. Major Manufacturers of Spinal Cord Stimulators Table 18. Major Manufacturers of Vagal Nerve Stimulators Table 19. Major Manufacturers of Sacral Nerve Stimulators Table 20. Major Manufacturers of Gastric Stimulators Table 21. Major Manufacturers of Others Table 22. Global Implantable Neurostimulators Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Implantable Neurostimulators Sales by Type (2021-2026) & (K Units) Table 24. Global Implantable Neurostimulators Sales by Type (2027-2032) & (K Units) Table 25. Global Implantable Neurostimulators Sales Market Share by Type (2021-2026) Table 26. Global Implantable Neurostimulators Sales Market Share by Type (2027-2032) Table 27. Global Implantable Neurostimulators Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 28. Global Implantable Neurostimulators Revenue by Type (2021-2026) & (K Units) Table 29. Global Implantable Neurostimulators Revenue by Type (2027-2032) & (K Units) Table 30. Global Implantable Neurostimulators Revenue Market Share by Type (2021-2026) Table 31. Global Implantable Neurostimulators Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Parkinson's Disease Table 33. Major Manufacturers of Epilepsy Table 34. Major Manufacturers of Pain Table 35. Major Manufacturers of Others Table 36. Global Implantable Neurostimulators Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Implantable Neurostimulators Sales by Application (2021-2026) & (K Units) Table 38. Global Implantable Neurostimulators Sales by Application (2027-2032) & (K Units) Table 39. Global Implantable Neurostimulators Sales Market Share by Application (2021-2026) Table 40. Global Implantable Neurostimulators Sales Market Share by Application (2027-2032) Table 41. Global Implantable Neurostimulators Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 42. Global Implantable Neurostimulators Revenue by Application (2021-2026) & (K Units) Table 43. Global Implantable Neurostimulators Revenue by Application (2027-2032) & (K Units) Table 44. Global Implantable Neurostimulators Revenue Market Share by Application (2021-2026) Table 45. Global Implantable Neurostimulators Revenue Market Share by Application (2027-2032) Table 46. Global Implantable Neurostimulators Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global Implantable Neurostimulators Sales by Region (2021-2026) & (K Units) Table 48. Global Implantable Neurostimulators Sales Market Share by Region (2021-2026) Table 49. Global Implantable Neurostimulators Sales Forecasted by Region (2027-2032) & (K Units) Table 50. Global Implantable Neurostimulators Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Implantable Neurostimulators Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. North America Implantable Neurostimulators Sales by Country (2021-2026) & (K Units) Table 53. North America Implantable Neurostimulators Sales by Country (2027-2032) & (K Units) Table 54. Europe Implantable Neurostimulators Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Europe Implantable Neurostimulators Sales by Country (2021-2026) & (K Units) Table 56. Europe Implantable Neurostimulators Sales by Country (2027-2032) & (K Units) Table 57. Asia Pacific Implantable Neurostimulators Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Asia Pacific Implantable Neurostimulators Sales by Country (2021-2026) & (K Units) Table 59. Asia Pacific Implantable Neurostimulators Sales by Country (2027-2032) & (K Units) Table 60. South America, Middle East and Africa Implantable Neurostimulators Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 61. South America, Middle East and Africa Implantable Neurostimulators Sales by Country (2021-2026) & (K Units) Table 62. South America, Middle East and Africa Implantable Neurostimulators Sales by Country (2027-2032) & (K Units) Table 63. Global Implantable Neurostimulators Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Implantable Neurostimulators Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Implantable Neurostimulators Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Implantable Neurostimulators Revenue Market Share by Region (2021-2026) Table 67. Global Implantable Neurostimulators Revenue Market Share by Region (2027-2032) Table 68. Medtronic Company Information Table 69. Medtronic Business Overview Table 70. Medtronic Implantable Neurostimulators Sales (K Units), Price (K US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Medtronic Implantable Neurostimulators Product Portfolio Table 72. Medtronic Recent Development Table 73. Boston Scientific Company Information Table 74. Boston Scientific Business Overview Table 75. Boston Scientific Implantable Neurostimulators Sales (K Units), Price (K US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Boston Scientific Implantable Neurostimulators Product Portfolio Table 77. Boston Scientific Recent Development Table 78. St. Jude Medical Company Information Table 79. St. Jude Medical Business Overview Table 80. St. Jude Medical Implantable Neurostimulators Sales (K Units), Price (K US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. St. Jude Medical Implantable Neurostimulators Product Portfolio Table 82. St. Jude Medical Recent Development Table 83. Cyberonics Company Information Table 84. Cyberonics Business Overview Table 85. Cyberonics Implantable Neurostimulators Sales (K Units), Price (K US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Cyberonics Implantable Neurostimulators Product Portfolio Table 87. Cyberonics Recent Development Table 88. NeuroPace Company Information Table 89. NeuroPace Business Overview Table 90. NeuroPace Implantable Neurostimulators Sales (K Units), Price (K US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. NeuroPace Implantable Neurostimulators Product Portfolio Table 92. NeuroPace Recent Development Table 93. Synapse Biomedical Company Information Table 94. Synapse Biomedical Business Overview Table 95. Synapse Biomedical Implantable Neurostimulators Sales (K Units), Price (K US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Synapse Biomedical Implantable Neurostimulators Product Portfolio Table 97. Synapse Biomedical Recent Development Table 98. NeuroSigma Company Information Table 99. NeuroSigma Business Overview Table 100. NeuroSigma Implantable Neurostimulators Sales (K Units), Price (K US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. NeuroSigma Implantable Neurostimulators Product Portfolio Table 102. NeuroSigma Recent Development Table 103. ReShape Lifesciences Company Information Table 104. ReShape Lifesciences Business Overview Table 105. ReShape Lifesciences Implantable Neurostimulators Sales (K Units), Price (K US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. ReShape Lifesciences Implantable Neurostimulators Product Portfolio Table 107. ReShape Lifesciences Recent Development Table 108. ElectroCore Medical Company Information Table 109. ElectroCore Medical Business Overview Table 110. ElectroCore Medical Implantable Neurostimulators Sales (K Units), Price (K US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. ElectroCore Medical Implantable Neurostimulators Product Portfolio Table 112. ElectroCore Medical Recent Development Table 113. Inspire Medical Company Information Table 114. Inspire Medical Business Overview Table 115. Inspire Medical Implantable Neurostimulators Sales (K Units), Price (K US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Inspire Medical Implantable Neurostimulators Product Portfolio Table 117. Inspire Medical Recent Development Table 118. NEUROS Company Information Table 119. NEUROS Business Overview Table 120. NEUROS Implantable Neurostimulators Sales (K Units), Price (K US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. NEUROS Implantable Neurostimulators Product Portfolio Table 122. NEUROS Recent Development Table 123. SPR Company Information Table 124. SPR Business Overview Table 125. SPR Implantable Neurostimulators Sales (K Units), Price (K US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. SPR Implantable Neurostimulators Product Portfolio Table 127. SPR Recent Development Table 128. IMTHERA Company Information Table 129. IMTHERA Business Overview Table 130. IMTHERA Implantable Neurostimulators Sales (K Units), Price (K US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. IMTHERA Implantable Neurostimulators Product Portfolio Table 132. IMTHERA Recent Development Table 133. NEVRO Company Information Table 134. NEVRO Business Overview Table 135. NEVRO Implantable Neurostimulators Sales (K Units), Price (K US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. NEVRO Implantable Neurostimulators Product Portfolio Table 137. NEVRO Recent Development Table 138. Key Raw Materials Table 139. Raw Materials Key Suppliers Table 140. Implantable Neurostimulators Distributors List Table 141. Implantable Neurostimulators Customers List Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Implantable Neurostimulators Product Image Figure 2. Global Implantable Neurostimulators Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Implantable Neurostimulators Market Size (2021-2032) & (US$ Million) Figure 4. Global Implantable Neurostimulators Sales (2021-2032) & (K Units) Figure 5. Global Implantable Neurostimulators Average Price (K US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Implantable Neurostimulators Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Deep Brain Stimulators Image Figure 9. Spinal Cord Stimulators Image Figure 10. Vagal Nerve Stimulators Image Figure 11. Sacral Nerve Stimulators Image Figure 12. Gastric Stimulators Image Figure 13. Others Image Figure 14. Global Implantable Neurostimulators Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Implantable Neurostimulators Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Implantable Neurostimulators Sales Market Share by Type (2021-2032) Figure 17. Global Implantable Neurostimulators Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 18. Global Implantable Neurostimulators Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Implantable Neurostimulators Revenue Market Share by Type (2021-2032) Figure 20. Parkinson's Disease Image Figure 21. Epilepsy Image Figure 22. Pain Image Figure 23. Others Image Figure 24. Global Implantable Neurostimulators Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Implantable Neurostimulators Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Implantable Neurostimulators Sales Market Share by Application (2021-2032) Figure 27. Global Implantable Neurostimulators Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 28. Global Implantable Neurostimulators Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Implantable Neurostimulators Revenue Market Share by Application (2021-2032) Figure 30. North America Implantable Neurostimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 31. North America Implantable Neurostimulators Sales Market Share by Country (2021-2032) Figure 32. U.S. Implantable Neurostimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Canada Implantable Neurostimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Mexico Implantable Neurostimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Implantable Neurostimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Europe Implantable Neurostimulators Sales Market Share by Country (2021-2032) Figure 37. Germany Implantable Neurostimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 38. France Implantable Neurostimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 39. U.K. Implantable Neurostimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Italy Implantable Neurostimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Netherlands Implantable Neurostimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Implantable Neurostimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Asia Pacific Implantable Neurostimulators Sales Market Share by Country (2021-2032) Figure 44. China Implantable Neurostimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Japan Implantable Neurostimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South Korea Implantable Neurostimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Southeast Asia Implantable Neurostimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 48. India Implantable Neurostimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Australia Implantable Neurostimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Implantable Neurostimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South America, Middle East and Africa Implantable Neurostimulators Sales Market Share by Country (2021-2032) Figure 52. Brazil Implantable Neurostimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 53. South Africa Implantable Neurostimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Saudi Arabia Implantable Neurostimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Turkey Implantable Neurostimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Argentina Implantable Neurostimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 57. UAE Implantable Neurostimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Egypt Implantable Neurostimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Chile Implantable Neurostimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Global Implantable Neurostimulators Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Implantable Neurostimulators Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Implantable Neurostimulators Revenue (2021-2032) & (US$ Million) Figure 63. North America Implantable Neurostimulators Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Implantable Neurostimulators Revenue (2021-2032) & (US$ Million) Figure 65. Europe Implantable Neurostimulators Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Implantable Neurostimulators Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Implantable Neurostimulators Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Implantable Neurostimulators Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Implantable Neurostimulators Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Implantable Neurostimulators Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Implantable Neurostimulators Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Deep Brain Stimulators
  • Spinal Cord Stimulators
  • Vagal Nerve Stimulators
  • Sacral Nerve Stimulators
  • Gastric Stimulators
  • Others
Applications
  • Parkinson's Disease
  • Epilepsy
  • Pain
  • Others
Companies covered
  • Medtronic
  • Boston Scientific
  • St. Jude Medical
  • Cyberonics
  • NeuroPace
  • Synapse Biomedical
  • NeuroSigma
  • ReShape Lifesciences
  • ElectroCore Medical
  • Inspire Medical
  • NEUROS
  • SPR
  • IMTHERA
  • NEVRO

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Implantable Neurostimulators Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Implantable Neurostimulators Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Implantable Neurostimulators Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Implantable Neurostimulators Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Implantable Neurostimulators Market Dynamics
  1. 2.1 Implantable Neurostimulators Industry Trends
  2. 2.2 Implantable Neurostimulators Industry Drivers
  3. 2.3 Implantable Neurostimulators Industry Opportunities and Challenges
  4. 2.4 Implantable Neurostimulators Industry Restraints
3 Implantable Neurostimulators Market by Manufacturers
  1. 3.1 Global Implantable Neurostimulators Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Implantable Neurostimulators Sales by Manufacturers (2021-2026)
  3. 3.3 Global Implantable Neurostimulators Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Implantable Neurostimulators Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Implantable Neurostimulators Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Implantable Neurostimulators Manufacturers, Product Type & Application
  7. 3.7 Global Implantable Neurostimulators Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Implantable Neurostimulators Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Implantable Neurostimulators Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Implantable Neurostimulators Tier 1, Tier 2, and Tier 3
4 Implantable Neurostimulators Market by Type
  1. 4.1 Implantable Neurostimulators Type Introduction
  2. 4.1.1 Deep Brain Stimulators
  3. 4.1.2 Spinal Cord Stimulators
  4. 4.1.3 Vagal Nerve Stimulators
  5. 4.1.4 Sacral Nerve Stimulators
  6. 4.1.5 Gastric Stimulators
  7. 4.1.6 Others
  8. 4.2 Global Implantable Neurostimulators Sales by Type
  9. 4.2.1 Global Implantable Neurostimulators Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Implantable Neurostimulators Sales by Type (2021-2032)
  11. 4.2.3 Global Implantable Neurostimulators Sales Market Share by Type (2021-2032)
  12. 4.3 Global Implantable Neurostimulators Revenue by Type
  13. 4.3.1 Global Implantable Neurostimulators Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Implantable Neurostimulators Revenue by Type (2021-2032)
  15. 4.3.3 Global Implantable Neurostimulators Revenue Market Share by Type (2021-2032)
5 Implantable Neurostimulators Market by Application
  1. 5.1 Implantable Neurostimulators Application Introduction
  2. 5.1.1 Parkinson's Disease
  3. 5.1.2 Epilepsy
  4. 5.1.3 Pain
  5. 5.1.4 Others
  6. 5.2 Global Implantable Neurostimulators Sales by Application
  7. 5.2.1 Global Implantable Neurostimulators Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Implantable Neurostimulators Sales by Application (2021-2032)
  9. 5.2.3 Global Implantable Neurostimulators Sales Market Share by Application (2021-2032)
  10. 5.3 Global Implantable Neurostimulators Revenue by Application
  11. 5.3.1 Global Implantable Neurostimulators Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Implantable Neurostimulators Revenue by Application (2021-2032)
  13. 5.3.3 Global Implantable Neurostimulators Revenue Market Share by Application (2021-2032)
6 Global Implantable Neurostimulators Sales by Region
  1. 6.1 Global Implantable Neurostimulators Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Implantable Neurostimulators Sales by Region (2021-2032)
  3. 6.2.1 Global Implantable Neurostimulators Sales by Region (2021-2026)
  4. 6.2.2 Global Implantable Neurostimulators Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Implantable Neurostimulators Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Implantable Neurostimulators Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Implantable Neurostimulators Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Implantable Neurostimulators Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Implantable Neurostimulators Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Implantable Neurostimulators Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Implantable Neurostimulators Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Implantable Neurostimulators Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Implantable Neurostimulators Revenue by Region
  1. 7.1 Global Implantable Neurostimulators Revenue by Region
  2. 7.1.1 Global Implantable Neurostimulators Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Implantable Neurostimulators Revenue by Region (2021-2026)
  4. 7.1.3 Global Implantable Neurostimulators Revenue by Region (2027-2032)
  5. 7.1.4 Global Implantable Neurostimulators Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Implantable Neurostimulators Revenue (2021-2032)
  8. 7.2.2 North America Implantable Neurostimulators Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Implantable Neurostimulators Revenue (2021-2032)
  11. 7.3.2 Europe Implantable Neurostimulators Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Implantable Neurostimulators Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Implantable Neurostimulators Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Implantable Neurostimulators Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Implantable Neurostimulators Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Medtronic
  2. 8.1.1 Medtronic Company Information
  3. 8.1.2 Medtronic Business Overview
  4. 8.1.3 Medtronic Implantable Neurostimulators Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Medtronic Implantable Neurostimulators Product Portfolio
  6. 8.1.5 Medtronic Recent Developments
  7. 8.2 Boston Scientific
  8. 8.2.1 Boston Scientific Company Information
  9. 8.2.2 Boston Scientific Business Overview
  10. 8.2.3 Boston Scientific Implantable Neurostimulators Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Boston Scientific Implantable Neurostimulators Product Portfolio
  12. 8.2.5 Boston Scientific Recent Developments
  13. 8.3 St. Jude Medical
  14. 8.3.1 St. Jude Medical Company Information
  15. 8.3.2 St. Jude Medical Business Overview
  16. 8.3.3 St. Jude Medical Implantable Neurostimulators Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 St. Jude Medical Implantable Neurostimulators Product Portfolio
  18. 8.3.5 St. Jude Medical Recent Developments
  19. 8.4 Cyberonics
  20. 8.4.1 Cyberonics Company Information
  21. 8.4.2 Cyberonics Business Overview
  22. 8.4.3 Cyberonics Implantable Neurostimulators Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Cyberonics Implantable Neurostimulators Product Portfolio
  24. 8.4.5 Cyberonics Recent Developments
  25. 8.5 NeuroPace
  26. 8.5.1 NeuroPace Company Information
  27. 8.5.2 NeuroPace Business Overview
  28. 8.5.3 NeuroPace Implantable Neurostimulators Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 NeuroPace Implantable Neurostimulators Product Portfolio
  30. 8.5.5 NeuroPace Recent Developments
  31. 8.6 Synapse Biomedical
  32. 8.6.1 Synapse Biomedical Company Information
  33. 8.6.2 Synapse Biomedical Business Overview
  34. 8.6.3 Synapse Biomedical Implantable Neurostimulators Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Synapse Biomedical Implantable Neurostimulators Product Portfolio
  36. 8.6.5 Synapse Biomedical Recent Developments
  37. 8.7 NeuroSigma
  38. 8.7.1 NeuroSigma Company Information
  39. 8.7.2 NeuroSigma Business Overview
  40. 8.7.3 NeuroSigma Implantable Neurostimulators Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 NeuroSigma Implantable Neurostimulators Product Portfolio
  42. 8.7.5 NeuroSigma Recent Developments
  43. 8.8 ReShape Lifesciences
  44. 8.8.1 ReShape Lifesciences Company Information
  45. 8.8.2 ReShape Lifesciences Business Overview
  46. 8.8.3 ReShape Lifesciences Implantable Neurostimulators Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 ReShape Lifesciences Implantable Neurostimulators Product Portfolio
  48. 8.8.5 ReShape Lifesciences Recent Developments
  49. 8.9 ElectroCore Medical
  50. 8.9.1 ElectroCore Medical Company Information
  51. 8.9.2 ElectroCore Medical Business Overview
  52. 8.9.3 ElectroCore Medical Implantable Neurostimulators Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 ElectroCore Medical Implantable Neurostimulators Product Portfolio
  54. 8.9.5 ElectroCore Medical Recent Developments
  55. 8.10 Inspire Medical
  56. 8.10.1 Inspire Medical Company Information
  57. 8.10.2 Inspire Medical Business Overview
  58. 8.10.3 Inspire Medical Implantable Neurostimulators Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Inspire Medical Implantable Neurostimulators Product Portfolio
  60. 8.10.5 Inspire Medical Recent Developments
  61. 8.11 NEUROS
  62. 8.11.1 NEUROS Company Information
  63. 8.11.2 NEUROS Business Overview
  64. 8.11.3 NEUROS Implantable Neurostimulators Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 NEUROS Implantable Neurostimulators Product Portfolio
  66. 8.11.5 NEUROS Recent Developments
  67. 8.12 SPR
  68. 8.12.1 SPR Company Information
  69. 8.12.2 SPR Business Overview
  70. 8.12.3 SPR Implantable Neurostimulators Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 SPR Implantable Neurostimulators Product Portfolio
  72. 8.12.5 SPR Recent Developments
  73. 8.13 IMTHERA
  74. 8.13.1 IMTHERA Company Information
  75. 8.13.2 IMTHERA Business Overview
  76. 8.13.3 IMTHERA Implantable Neurostimulators Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 IMTHERA Implantable Neurostimulators Product Portfolio
  78. 8.13.5 IMTHERA Recent Developments
  79. 8.14 NEVRO
  80. 8.14.1 NEVRO Company Information
  81. 8.14.2 NEVRO Business Overview
  82. 8.14.3 NEVRO Implantable Neurostimulators Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 NEVRO Implantable Neurostimulators Product Portfolio
  84. 8.14.5 NEVRO Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Implantable Neurostimulators Value Chain Analysis
  2. 9.1.1 Implantable Neurostimulators Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Implantable Neurostimulators Production Mode & Process
  6. 9.2 Implantable Neurostimulators Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Implantable Neurostimulators Distributors
  9. 9.2.3 Implantable Neurostimulators Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst